During the last three decades, the biopharmaceutical industry has invested significantly in new and improved vaccines. The results have provided remarkable new ways to prevent cases of cervical cancer, meningitis, pneumonia, pandemic influenza, and rotavirus diseases.
The collaborative efforts of the Centers for Disease Control and Prevention (CDC), World Health Organization (WHO), national governments and industry have led to major progress in addressing global immunization goals and reducing illness and death due to vaccine-preventable diseases. Read the full story.